Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1976 1
1977 6
1978 1
1979 5
1980 5
1981 5
1982 1
1983 1
1984 1
1985 4
1986 7
1987 4
1988 2
1989 5
1990 8
1991 6
1992 8
1993 6
1994 4
1996 1
1997 1
1999 3
2000 3
2001 1
2002 2
2004 2
2005 3
2007 3
2008 1
2009 1
2011 1
2012 3
2013 3
2016 2
2017 1
2018 4
2019 1
2020 4
2021 4
2022 2
2023 5
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30145929 Free article. Clinical Trial.
Cardiac Amyloidosis.
Bloom MW, Gorevic PD. Bloom MW, et al. Among authors: gorevic pd. Ann Intern Med. 2023 Mar;176(3):ITC33-ITC48. doi: 10.7326/AITC202303210. Epub 2023 Mar 14. Ann Intern Med. 2023. PMID: 36913688 Review.
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.
Benson MD, Waddington-Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, Planté-Bordeneuve V, Barroso FA, Merlini G, Obici L, Scheinberg M, Brannagan TH 3rd, Litchy WJ, Whelan C, Drachman BM, Adams D, Heitner SB, Conceição I, Schmidt HH, Vita G, Campistol JM, Gamez J, Gorevic PD, Gane E, Shah AM, Solomon SD, Monia BP, Hughes SG, Kwoh TJ, McEvoy BW, Jung SW, Baker BF, Ackermann EJ, Gertz MA, Coelho T. Benson MD, et al. Among authors: gorevic pd. N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793. N Engl J Med. 2018. PMID: 29972757 Free article. Clinical Trial.
Amyloidosis.
Gorevic PD, Franklin EC. Gorevic PD, et al. Annu Rev Med. 1981;32:261-71. doi: 10.1146/annurev.me.32.020181.001401. Annu Rev Med. 1981. PMID: 7013666 Review. No abstract available.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Free article. Clinical Trial.
Comprehensive clinical phenotype, genotype and therapy in Yao syndrome.
Nomani H, Wu S, Saif A, Hwang F, Metzger J, Navetta-Modrov B, Gorevic PD, Aksentijevich I, Yao Q. Nomani H, et al. Among authors: gorevic pd. Front Immunol. 2024 Sep 20;15:1458118. doi: 10.3389/fimmu.2024.1458118. eCollection 2024. Front Immunol. 2024. PMID: 39372397 Free PMC article.
Cryoglobulinemia.
Dispenzieri A, Gorevic PD. Dispenzieri A, et al. Among authors: gorevic pd. Hematol Oncol Clin North Am. 1999 Dec;13(6):1315-49. doi: 10.1016/s0889-8588(05)70129-5. Hematol Oncol Clin North Am. 1999. PMID: 10626153 Review.
Evaluation of cryoglobulins.
Kallemuchikkal U, Gorevic PD. Kallemuchikkal U, et al. Among authors: gorevic pd. Arch Pathol Lab Med. 1999 Feb;123(2):119-25. doi: 10.5858/1999-123-0119-EOC. Arch Pathol Lab Med. 1999. PMID: 10050784 Free article. Review.
The physical urticarias.
Gorevic PD, Kaplan AP. Gorevic PD, et al. Int J Dermatol. 1980 Oct;19(8):417-35. doi: 10.1111/j.1365-4362.1980.tb05893.x. Int J Dermatol. 1980. PMID: 6161901 Review. No abstract available.
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Adams D, Wixner J, Polydefkis M, Berk JL, Conceição IM, Dispenzieri A, Peltier A, Ueda M, Bender S, Capocelli K, Jay PY, Yureneva E, Obici L; patisiran Global OLE study group. Adams D, et al. JAMA Neurol. 2025 Mar 1;82(3):228-236. doi: 10.1001/jamaneurol.2024.4631. JAMA Neurol. 2025. PMID: 39804640 Free PMC article. Clinical Trial.
133 results